CONVERGENEPHARMA.COM
Home - ConverGeneDeveloping First-in-Class Dual Inhibitors Targeting Both BET Bromodomains and Dopamine Receptor 2 for the Treatment of Cancer
http://www.convergenepharma.com/
Developing First-in-Class Dual Inhibitors Targeting Both BET Bromodomains and Dopamine Receptor 2 for the Treatment of Cancer
http://www.convergenepharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
0.3 seconds
16x16
32x32
64x64
128x128
160x160
192x192
256x256
Noble Life Sciences
stephen horrigan
22 Fi●●●●●ld Rd
Sui●●●280
Gait●●●●burg , Maryland, 20878
United States
View this contact
Noble Life Sciences
stephen horrigan
22 Fi●●●●●ld Rd
Sui●●●280
Gait●●●●burg , Maryland, 20878
United States
View this contact
Noble Life Sciences
stephen horrigan
22 Fi●●●●●ld Rd
Sui●●●280
Gait●●●●burg , Maryland, 20878
United States
View this contact
BUY YOUR DOMAIN
12
YEARS
8
MONTHS
19
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
1
SITE IP
72.167.241.180
LOAD TIME
0.329 sec
SCORE
6.2
Home - ConverGene | convergenepharma.com Reviews
https://convergenepharma.com
Developing First-in-Class Dual Inhibitors Targeting Both BET Bromodomains and Dopamine Receptor 2 for the Treatment of Cancer
convergenepharma.com
Scientific Advisory Board - ConverGenePharma
http://convergenepharma.com/about-ConVergene/scientific-advisory-board
Jian Jin, Ph.D. Dr Jin is currently. Professor of Structural and Chemical Biology, Oncological Sciences, and Pharmacology at. The Icahn School of Medicine at Mount Sinai. Over the last six years, Dr. Jin's research has. Focused on discovering chemical probes of protein methyltransferases and functionally selective ligands of G protein-coupled receptors. Prior to joining the faculty of the Icahn School of Medicine,. Before moving to the University of North Carolina at Chapel Hill,. Stefan Knapp, Ph.D.
ConverGenePharma
http://convergenepharma.com/home
Developing Bromodomain and ExtraTerminal (BET) Protein Inhibitors. ConverGene is an early-stage biopharmaceutical company focusing on the discovery and development of novel cancer drugs targeting the root regulatory mechanisms within cancer cells. Our primary goal is the development of small-molecule drugs that target bromodomains, a well-characterized structural feature of proteins which mediate epigenetic changes in DNA and DNA-packaging proteins. Inhibition of BRD4 Suppresses MYC. ACS Med Chem Lett...
Report Abuse
http://convergenepharma.com/system/app/pages/reportAbuse
By submitting this form, you are alerting the Google Sites team that this site has content that is in violation of our Terms of Use. Why are you reporting the content on this Site as inappropriate? This Site contains spam. This Site contains phishing. This Site contains malware. This Site contains sexually explicit material (like pornography or nudity). This Site contains content that is harassing me or someone else. This Site promotes violence or has hate speech.
About ConverGene - ConverGenePharma
http://convergenepharma.com/about-ConVergene
ConverGene has discovered and developed a propriety library of small molecules that have profound effects on the MYC gene, a critical oncogene that controls progression of cancer. From this compound library, we have established our first program to develop novel BRD4 inhibitors. ConverGene scientists in conjunction with University of Maryland Baltimore researchers. Design new class of dual BET/PLK1 inhibitors. ACS Med Chem Lett. 2015 May 18;6(7):764-9. ConverGene receives $25,000 IMPACT grant award.
Management Team - ConverGenePharma
http://convergenepharma.com/about-ConVergene/management-team
Jeffrey W. Strovel, Ph.D. President and Chief Executive Officer. Dr Strovel has led programs for small-molecule drug discovery and development including drug target discovery, hit-to-lead, drug lead optimization, and biomarker discovery and validation. Earlier in his career, Dr. Strovel held positions at the University of Maryland and the National Cancer Institute. Sunil Sharma, MD, FACP. He also serves as the CMO for Beta Cat Pharmaceuticals. Dr Sharma has been involved with over 150 phase 1 and 2 clini...
TOTAL PAGES IN THIS WEBSITE
7
Portfolio - Noble Bioventures
http://www.noblebioventures.com/portfolio
NexImmune Announces $3 Million Financing. Noble Life Sciences Acquires Spring Valley Labs. Specializes in developing targeted small molecule cancer therapies that affect a novel node in the beta catenin cellular control pathway. Beta Cat has a stellar management and advisory team with successful leadership experience in all aspects of cancer drug discovery and development. The company’s first product is poised to enter clinical trials during the next 12-18 months. Nanotechnology developed at Johns Hopkin...
TOTAL LINKS TO THIS WEBSITE
1
convergency :: home
Facilitating sustainable change in individuals, teams and organisations. Facilitating Sustainable Change in Individuals, Teams and Organisations. We help leadership teams overcome the cultural and organisational challenges of embedding sustainability within businesses. Often the biggest obstacle to sustainability implementations is the intangible stuff behaviours, values and beliefs. Sustainability initiatives, along with any organisational change programme, begin and end with people.
The Convergency Room
Friday, September 18, 2009. First meeting was a success. My team drove out at 6:30 am on Wednesday to Independence, Missouri, to meet the Examiner staff. The meeting went very well. The staff had many questions about Facebook and implementation, which we were able to answer. Everyone involved is excited about the project, and I feel good about the future. Posted by Tim Chappell at 4:09 PM. Links to this post. Monday, July 06, 2009. Do I need another blog post? V= VQX2Xn7tI). But I know I have a found...
convergene.com
Business-Class Web Hosting by (mt) Media Temple
Mt) Media Temple,Inc. - Web Hosting Built to Scale. This page has been generated automatically. If you are the server administrator and you feel that you have reached this page in error, then try completing the following steps. Please consult the (mt) KnowledgeBase. Articles below for more information. 1 Log in to Plesk ». 2 Make sure domain is added ». 3 Create your subscription ». View all related articles ». 24-7 Global Support - 877-578-4000. 1998-2012 (mt) Media Temple, Inc. Legal.
Home - ConverGene
Both BET Bromodomains and. Dopamine Receptor 2 for the. Treatment of Rare Diseases.
1&1 This domain name is registered
This domain name has been registered. By 1&1 and is online. If this is your domain name, please log in to. Your 1&1 Control Panel. 160;to set up your website. Still looking for the right domain? As a leading web hosting provider, 1&1 offers businesses and indiviuals. The best online tools to achieve online success. At the best prices. E-mail solutions for every need -. The simple solution to a. Affordable web hosting with the. Easy-to-use solutions for any.
| ConvergeNet Projects Group
Cannes Film Festival 2017. ConvergeNet Projects Group provides scalable and affordable strategic marketing communications, business consulting and media entertainment production services. We develop partnerships and new markets locally and internationally. Our integrated marketing and corporate communication services converge the worlds of traditional media, digital media, social media and the Internet – hence, the name ConvergeNet. ConvergeNet Real Estate Marketing.
www.convergenet.com coming soon
Afrihost - pure internet joy. Has been registered on behalf of a client. When will the site be ready? We're not quite sure, but they're probably working on it. We suggest contacting them directly to find out. Afrihost - Pure Internet Joy.
Converge Networks - Cloud, Infraestrura e Segurança de TI | Converge Networks – Infraestrutura e Segurança
ENQUANTO VOCÊ ADMINISTRA SUA EMPRESA,. NÓS CUIDAMOS DA TI PARA SUA TRANQUILIDADE. DIMINUA OS RISCOS PARA OS NEGÓCIOS. USE O MELHOR ANTIVÍRUS DO MUNDO NA SUA EMPRESA. NGN FIREWALL, VPN, IPS, WEB FILTER, MAIL FILTER. TUDO EM UM ÚNICO PRODUTO FÁCIL DE GERENCIAR. NÃO ARRISQUE A REPUTAÇÃO DA SUA EMPRESA. Somos uma empresa de TI que valoriza a qualidade e não a quantidade e se concentra em estabelecer relacionamentos de longo prazo com os clientes. Rua Domingos Martins, 121 5o Andar. RS 55 51 3013-3014.
Web hosting provider - Bluehost.com - domain hosting - PHP Hosting - cheap web hosting - Frontpage Hosting E-Commerce Web Hosting Bluehost
Web Hosting - courtesy of www.bluehost.com.
